EdiGene
A biotechnology company using genetic editing technologies to develop therapies for the treatment of cancer and genetic diseases.
9
Funding Rounds
$262.0m
Money raised
| Name | Phone | Social networks | |
|---|---|---|---|
| We* We****** | - | - | - |
Funding series
Funding Series Analysis
The company EdiGene has raised a total of $15m in funding over 9 rounds.
Key Insights:
- EdiGene Series B round, April 2019: $15m
- EdiGene Series A round, February 2019: $10m
- EdiGene Series A round, August 2018: $14.5m
- EdiGene Series A round, December 2017: $15m
- EdiGene Series B round, April 2021: $61m
- EdiGene Inc Series B round October 2020: $67m
- EdiGene Series B round, October 2020: $67m
- EdiGene Series A round, September 2019: $12.5m
EdiGene Series B round, April 2019
$15m
EdiGene Series A round, February 2019
$10m
EdiGene Series A round, August 2018
$14.5m
EdiGene Series A round, December 2017
$15m
EdiGene Series B round, April 2021
$61m
EdiGene Inc Series B round October 2020
$67m
EdiGene Series B round, October 2020
$67m
EdiGene Series A round, September 2019
$12.5m
Industries
EdiGene is active in the following industries: